BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8985022)

  • 1. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
    Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
    Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
    Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.
    Teo PM; Leung SF; Lee WY; Zee B
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):445-58. PubMed ID: 10661353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
    Ren Y; Zhao Q; Liu H; Huang Y; Wang Z; Cao X; Teh BS; Wen B
    BMC Cancer; 2014 Nov; 14():894. PubMed ID: 25432818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx.
    Levendag PC; Schmitz PI; Jansen PP; Eijkenboom WM; Visser AG; Kolkman-Deurloo IK; Sipkema D; Visch LL; Senan S
    J Clin Oncol; 1998 Jun; 16(6):2213-20. PubMed ID: 9626223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
    Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
    Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
    Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
    Ozyar E; Yildz F; Akyol FH; Atahan IL
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
    Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
    Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
    Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
    Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
    Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
    Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals.
    Teo PM; Leung SF; Fowler J; Leung TW; Tung Y; O SK; Lee WY; Zee B
    Radiother Oncol; 2000 Nov; 57(2):155-66. PubMed ID: 11054519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
    Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
    Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
    Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.